Testing effectiveness (Phase 2)Study completedNCT06131372
What this trial is testing
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesObesity
Novo Nordisk A/S 626